(HealthDay)—Azedra (iobenguane) has been approved by the U.S. Food and Drug Administration to treat people 12 and older with rare
Continue reading »
Home »
Opdivo (nivolumab) + Low-Dose Yervoy (ipilimumab) Combination Approved for Previously Treated MSI-H/dMMR Metastatic Colorectal Cancer
PRINCETON, N.J.– July 11, 2018 (BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) today announced Opdivo (nivolumab) 3 mg/kg plus low-dose Yervoy
Continue reading »
‘BioSimilar’ drug approved to treat certain types of anemia
(HealthDay)—Retacrit (epoetin alfa-epbx) has been approved by the U.S. Food and Drug Administration as the first “biosimilar” to the anemia
Continue reading »
Robotics startup launches first medically approved 3-D printed bionic arms
A robotics company which began as a startup at Bristol Robotics Laboratory (BRL) has launched the world’s first medically certified
Continue reading »
First drug approved for most common inherited kidney disease
The U.S. Food and Drug Administration has approved the first drug to slow kidney decline in patients with the most
Continue reading »
New bacteria-resistant materials approved for trials on humans
A medical device coated with new bacteria resistant materials, discovered by a team at the University of Nottingham, has been
Continue reading »